Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 532 participants.

Also called NCT05820880

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 532 participants (enrolled count) (from the registry)
Sponsor
Institut de Recherches Internationales Servier (from the registry)
Registry
  • NCT NCT05820880
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05820880. Randomized; double masking; primary purpose treatment. Start 2019-05-06 (actual); primary completion 2022-02-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
Condition
Hypertension
Intervention (Drug)
Fixed [Per/Ind/Aml]
Intervention (Drug)
Free [Per/Ind + Aml]
Lead sponsor
Institut de Recherches Internationales Servier (class: other)

Record details

Record id
cardio:ct-nct05820880
Content hash
9fa735f0af0fac119d1f89c6a4345368a18800d2800d20fedfa9261b2414294d